InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 05/06/2019 8:20:42 AM

Monday, May 06, 2019 8:20:42 AM

Post# of 8169
News: $CLRB Cellectar Reports First Quarter 2019 Financial Results and Provides a Corporate Update

Reported positive top-line results from relapsed/refractory multiple myeloma cohort in ongoing Phase 2 clinical study of CLR 131 Announced median overall survival rate of 22 months in Cohorts 1-4 in its ongoing Phase 1 clinical study of CLR 131 in relapsed/refractory multiple myeloma ...

Find out more https://marketwirenews.com/news-releases/cellectar-reports-first-quarter-2019-financial-results-and-provides-a-corporate-update-8122574.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLRB News